3,17 €
0,13 % heute
L&S, 27. Mai, 13:52 Uhr
ISIN
US00650F1093
Symbol
ADPT
Berichte

Adaptive Biotechnologies Corp Aktie News

Positiv
InvestorPlace
4 Tage alt
To be completely upfront, small-cap stocks to buy are risky. They're the equivalent of plus-money bets or plus odds.
Positiv
The Motley Fool
5 Tage alt
Cathie Wood bought shares of Shopify, Intellia, and Adaptive Biotechnologies on Tuesday. Shopify has surrendered 26% of its value over the past two weeks since posting disappointing guidance.
Positiv
The Motley Fool
19 Tage alt
On a relatively sleepy day for the market, the biotech enjoyed a decent little price pop on earnings. Its first quarter results topped analyst estimates on both the top and bottom lines.
Neutral
Seeking Alpha
19 Tage alt
Adaptive Biotechnologies Corporation. (NASDAQ:ADPT ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Karina Calzadilla - Head, IR Chad Robins - CEO and Co-founder Kyle Piskel - CFO Susan Bobulsky - Senior Vice President, Diagnostics, clonoSEQ Conference Call Participants Mark Massaro - BTIG David Westenberg - Piper Sandberg Tom Stevens - TD Cowen Operator Good day a...
Neutral
GlobeNewsWire
20 Tage alt
SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended March 31, 2024.
Neutral
GlobeNewsWire
etwa ein Monat alt
SEATTLE, April 17, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024. Company management ...
Neutral
GlobeNewsWire
etwa 2 Monate alt
SEATTLE, April 02, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced a business update, including the conclusion of its recent strategic review, preliminary revenue for the first quarter ended...
Positiv
InvestorPlace
2 Monate alt
This month in March is a great time to pick up shares in these best penny stocks to buy. I chose the companies due to their strong fundamentals and potential for significant upside.
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen